AC
AGN

Alleghany Corporation’s Allergan plc AGN Stock Holding History

Alleghany Corporation’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-240,000
Closed -$50.4M – 37
2016
Q4 		$50.4M Sell
240,000
-260,000
-52% -$53.9M 1.74% 22
2016
Q3 		$115M Hold
500,000
– – 4.15% 10
2016
Q2 		$116M Buy
+500,000
New +$115M 4.43% 8

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alleghany Corporation's AGN Position: Q1 2017 in Review

Alleghany Corporation sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 240,000 shares — an estimated $50.4M sold.

Alleghany Corporation first reported a position in AGN in Q2 2016 and held it in 3 quarters. The position peaked at $116M in Q2 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Alleghany Corporation reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Alleghany Corporation sold 240,000 Allergan plc shares in Q1 2017, an estimated $50.4M.
  • Alleghany Corporation first reported a position in Allergan plc in Q2 2016 and held it in 3 quarters.
  • Alleghany Corporation's Allergan plc position peaked at $116M in Q2 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Alleghany Corporation's 13F filing for Q1 2017, filed 12 May 2017.